Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, England.
BMC Infect Dis. 2022 Jun 22;22(1):567. doi: 10.1186/s12879-022-07551-8.
A recent publication in BMC Infectious Diseases concerning the use of convalescent plasma for the treatment of COVID-19 had a number of major issues. This correspondence details specific instances of unclear reporting as well as major omissions when discussing the context of the trial. These render the study's findings and conclusions misleading.
最近发表在《BMC 传染病》杂志上的一篇关于使用恢复期血浆治疗 COVID-19 的文章存在一些重大问题。本通信详细说明了在报告方面不明确的具体情况，以及在讨论试验背景时的重大遗漏。这些问题使得研究的发现和结论具有误导性。
